首页> 外文期刊>Infection and immunity >Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.
【24h】

Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.

机译:使用单克隆抗-muramyl二肽抗体可显着增强muramyl二肽对蛋白质抗原和对合成的弱免疫原的佐剂活性。

获取原文
           

摘要

Priming of mice with complexes of antigen coupled to muramyl dipeptide and monoclonal anti-muramyl dipeptide antibodies enhanced the adjuvant activity of muramyl dipeptide on the humoral response to the antigen. The enhancement did not occur with free (uncoupled) muramyl dipeptide and required the presence of an adjuvant-active hapten within the complex as well as the Fc fragment of the monoclonal antibody. This system proved highly effective in eliciting antibodies to synthetic weak immunogens whereas muramyl dipeptide, on its own, exerts very little or no adjuvant activity. The effect was not due to a general polyclonal activation and was restricted to the antigen coupled to the synthetic adjuvant. Possible pathways involved in this phenomenon are discussed.
机译:用与鼠王氨酰二肽和单克隆抗-村鼠二肽抗体偶联的抗原复合物引发小鼠增强鼠王二酰二肽对抗原的体液反应的佐剂活性。游离的(未偶联的)戊二酰二肽不会发生这种增强,而是需要复合物中的单克隆抗体Fc片段中存在佐剂活性的半抗原。事实证明,该系统在引发针对合成的弱免疫原的抗体方面非常有效,而穆拉美二肽本身仅发挥极少或没有佐剂活性。该作用不是由于普遍的多克隆激活所致,而是限于与合成佐剂偶联的抗原。讨论了此现象可能涉及的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号